Clinical Trials Directory

Trials / Unknown

UnknownNCT04770857

Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis

Evaluation of Post-Post-Endoscopic Retrograde Cholangiopancreaticography Pain (ERCP) as a Predictor for Post-ERCP Pancreatitis

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Nicola Frei · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pancreatitis is the most common complication after ERCP, although its frequency varies significantly depending on the study from \< 2% up to 40%. Based upon data from studies that have included unselected patients, post-ercp pancreatitis (PEP) is mild, moderate, and severe in 45%, 44%, and 11% of cases, respectively. Dysfunction of the sphincter Oddi, female gender, younger age, previous history of pancreatitis, prolonged procedure time and pancreatic guidewire passages are well-known independent risk factors for PEP. This study will assess whether the development of PEP can be predicted by Visual analogue scale (VAS) level 1 hour after ERCP.

Conditions

Interventions

TypeNameDescription
OTHERVisual analogue scalePost procedural pain assessment using the visual analogue scale (VAS) will be performed in patients undergoing ERCP

Timeline

Start date
2021-09-01
Primary completion
2023-05-01
Completion
2023-08-01
First posted
2021-02-25
Last updated
2021-07-29

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04770857. Inclusion in this directory is not an endorsement.